Ignite Creation Date:
2024-05-06 @ 3:56 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02415374
Status:
COMPLETED
Last Update Posted:
2021-03-10
First Post:
2015-04-06
Brief Title:
Bioavailability and Metabolism of Avenanthramide a Novel Oat Phytochemical
Sponsor:
PepsiCo Global RD
Organization:
PepsiCo Global RD
Study Overview
Official Title:
Bioavailability and Metabolism of Avenanthramide a Novel Oat Phytochemical
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to examine whether orally ingested oat avenanthramides AVA in oat flour cookies are bioavailable in humans by measuring plasma and urine concentrations of AVAs and their potential metabolites after ingestion The blood and urine concentrations will be quantified at several different time points after the oat flour cookies are consumed to characterize the concentration-time profile
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None